Details for New Drug Application (NDA): 202494
✉ Email this page to a colleague
The generic ingredient in SODIUM BICARBONATE is sodium bicarbonate. There are one thousand four hundred and seventy-two drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the sodium bicarbonate profile page.
Summary for 202494
Tradename: | SODIUM BICARBONATE |
Applicant: | Hospira |
Ingredient: | sodium bicarbonate |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 202494
Mechanism of Action | Osmotic Activity |
Physiological Effect | Increased Large Intestinal Motility Inhibition Large Intestine Fluid/Electrolyte Absorption |
Suppliers and Packaging for NDA: 202494
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
SODIUM BICARBONATE | sodium bicarbonate | INJECTABLE;INJECTION | 202494 | ANDA | Henry Schein, Inc. | 0404-9984 | 0404-9984-50 | 1 SYRINGE in 1 BAG (0404-9984-50) / 50 mL in 1 SYRINGE |
SODIUM BICARBONATE | sodium bicarbonate | INJECTABLE;INJECTION | 202494 | ANDA | Hospira, Inc. | 0409-4916 | 0409-4916-14 | 10 CARTON in 1 PACKAGE (0409-4916-14) / 1 SYRINGE in 1 CARTON / 50 mL in 1 SYRINGE (0409-4916-24) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 0.9MEQ/ML | ||||
Approval Date: | Mar 6, 2017 | TE: | AP | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 1MEQ/ML | ||||
Approval Date: | Mar 6, 2017 | TE: | AP | RLD: | No |
Complete Access Available with Subscription